The review looks at concerns about misuse as demand for GLP-1 drugs grows, and points to how little evidence guides their use beyond approved conditions.
Recap by typeshit. Full story at News-Medical.
Researchers found self-reported GLP-1 use climbed from March 2024 to October 2025, mostly for weight loss, through channels insurance data may not capture.
The study is looking for women with hot flashes and night sweats and a BMI above 30. Mayo Clinic has the full eligibility rules and how to sign up.
A matched cohort study in Inflammatory Bowel Diseases found remission odds nearly six times higher on GLP-1 drugs, and weight loss alone didn't explain it.
She says women with endometriosis taking GLP-1 drugs tell her bloating, pain and fatigue feel better. These are patient reports, not trial results.
Even genuine pens with foreign prescriptions are seized. Lawmakers and a regulatory official now want a review, as Mounjaro costs over three times more in Korea than Japan.
The post warns that people in their 50s and 60s may blame vision changes on age or screens, when researchers have tied the drug in Ozempic to a rare cause of sudden sight loss.
Loading…